RhumbLine Advisers
IMGN

RhumbLine Advisers’s Immunogen Inc IMGN Stock Holding History

RhumbLine Advisers’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-361,594
Closed -$10.7M – 4295
2023
Q4 		$10.7M Sell
361,594
-2,802
-0.8% -$55.8K 0.01% 1018
2023
Q3 		$5.78M Buy
364,396
+449
+0.1% +$7.47K 0.01% 1260
2023
Q2 		$6.87M Buy
363,947
+43,445
+14% +$513K 0.01% 1197
2023
Q1 		$1.23M Sell
320,502
-2,046
-0.6% -$8.72K ﹤0.01% 2035
2022
Q4 		$1.6M Buy
322,548
+3,220
+1% +$17.5K ﹤0.01% 1904
2022
Q3 		$1.53M Buy
319,328
+20,656
+7% +$109K ﹤0.01% 1917
2022
Q2 		$1.34M Buy
298,672
+46,584
+18% +$202K ﹤0.01% 1987
2022
Q1 		$1.2M Sell
252,088
-16,232
-6% -$89.9K ﹤0.01% 2060
2021
Q4 		$1.99M Sell
268,320
-3,286
-1% -$20.4K ﹤0.01% 1886
2021
Q3 		$1.54M Buy
271,606
+4,587
+2% +$26.5K ﹤0.01% 2030
2021
Q2 		$1.76M Sell
267,019
-15,673
-6% -$109K ﹤0.01% 2011
2021
Q1 		$2.29M Sell
282,692
-9,033
-3% -$73.8K ﹤0.01% 1850
2020
Q4 		$1.88M Buy
291,725
+32,798
+13% +$191K ﹤0.01% 1877
2020
Q3 		$932K Sell
258,927
-30,774
-11% -$124K ﹤0.01% 2019
2020
Q2 		$1.33M Buy
289,701
+60,384
+26% +$257K ﹤0.01% 1923
2020
Q1 		$782K Buy
229,317
+20,352
+10% +$89K ﹤0.01% 1987
2019
Q4 		$1.07M Buy
208,965
+2,542
+1% +$8.63K ﹤0.01% 2046
2019
Q3 		$500K Buy
206,423
+7,929
+4% +$21.1K ﹤0.01% 2326
2019
Q2 		$431K Buy
198,494
+14,821
+8% +$35K ﹤0.01% 2423
2019
Q1 		$498K Sell
183,673
-5,155
-3% -$22.3K ﹤0.01% 2331
2018
Q4 		$906K Buy
188,828
+62,794
+50% +$381K ﹤0.01% 2062
2018
Q3 		$1.19M Buy
126,034
+801
+0.6% +$7.7K ﹤0.01% 1925
2018
Q2 		$1.22M Buy
125,233
+30,301
+32% +$319K ﹤0.01% 1927
2018
Q1 		$999K Buy
94,932
+4,083
+4% +$40.3K ﹤0.01% 1946
2017
Q4 		$582K Sell
90,849
-8,937
-9% -$55.1K ﹤0.01% 2176
2017
Q3 		$763K Buy
99,786
+1,610
+2% +$10.7K ﹤0.01% 2113
2017
Q2 		$698K Sell
98,176
-3,767
-4% -$17.2K ﹤0.01% 2146
2017
Q1 		$395K Sell
101,943
-4,226
-4% -$12.3K ﹤0.01% 2363
2016
Q4 		$217K Sell
106,169
-27
-0% -$54 ﹤0.01% 2640
2016
Q3 		$285K Sell
106,196
-4,175
-4% -$12.1K ﹤0.01% 2513
2016
Q2 		$340K Buy
110,371
+16,312
+17% +$102K ﹤0.01% 2454
2016
Q1 		$801K Buy
94,059
+230
+0.2% +$1.95K ﹤0.01% 1942
2015
Q4 		$1.27M Buy
93,829
+6,255
+7% +$77K ﹤0.01% 1645
2015
Q3 		$841K Sell
87,574
-1,183
-1% -$17.3K ﹤0.01% 1881
2015
Q2 		$1.28M Sell
88,757
-5,990
-6% -$65.8K ﹤0.01% 1709
2015
Q1 		$848K Buy
94,747
+14,850
+19% +$108K ﹤0.01% 1966
2014
Q4 		$487K Sell
79,897
-3,145
-4% -$28.8K ﹤0.01% 2296
2014
Q3 		$879K Sell
83,042
-6,390
-7% -$72.3K ﹤0.01% 1848
2014
Q2 		$1.06M Sell
89,432
-10,605
-11% -$133K ﹤0.01% 1782
2014
Q1 		$1.49M Sell
100,037
-4,020
-4% -$63.4K ﹤0.01% 1543
2013
Q4 		$1.53M Sell
104,057
-550
-0.5% -$8.45K ﹤0.01% 1534
2013
Q3 		$1.78M Sell
104,607
-1,427
-1% -$25.1K 0.01% 1421
2013
Q2 		$1.76M Buy
+106,034
New +$1.72M 0.01% 1396

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

RhumbLine Advisers's IMGN Position: Q1 2024 in Review

RhumbLine Advisers sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 361,594 shares — an estimated $10.7M sold.

RhumbLine Advisers first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $10.7M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • RhumbLine Advisers reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 361,594 Immunogen Inc shares in Q1 2024, an estimated $10.7M.
  • RhumbLine Advisers first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • RhumbLine Advisers's Immunogen Inc position peaked at $10.7M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.